Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Net Income (2022 - 2025)

Envoy Medical's Net Income history spans 4 years, with the latest figure at -$6.2 million for Q3 2025.

  • For Q3 2025, Net Income fell 17.96% year-over-year to -$6.2 million; the TTM value through Sep 2025 reached -$22.4 million, up 14.69%, while the annual FY2024 figure was -$20.1 million, 9.26% down from the prior year.
  • Net Income for Q3 2025 was -$6.2 million at Envoy Medical, down from -$5.7 million in the prior quarter.
  • Across five years, Net Income topped out at $12.5 million in Q1 2022 and bottomed at -$11.1 million in Q4 2023.
  • The 4-year median for Net Income is -$4.9 million (2024), against an average of -$2.2 million.
  • The largest YoY upside for Net Income was 55.62% in 2024 against a maximum downside of 785.52% in 2024.
  • A 4-year view of Net Income shows it stood at -$2.0 million in 2022, then crashed by 453.4% to -$11.1 million in 2023, then skyrocketed by 55.62% to -$4.9 million in 2024, then decreased by 25.26% to -$6.2 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Net Income are -$6.2 million (Q3 2025), -$5.7 million (Q2 2025), and -$5.6 million (Q1 2025).